Taking medication consistently is one of the most effective ways to maintain remission in inflammatory bowel disease (IBD), yet many people find it difficult to stay on track. Missed doses, interruptions and early discontinuation are common, even when treatment is working. Understanding why adherence matters and identifying practical strategies to support it can make a […]
Corticosteroids are among the most effective tools for bringing active inflammatory bowel disease (IBD) under control quickly. Many patients with Crohn’s disease or ulcerative colitis will be prescribed them during a flare. Yet steroids are not intended for long-term use, and stopping them safely requires planning. Understanding when they help, how to taper off, and […]
If you have Crohn’s disease or ulcerative colitis, you have probably noticed that a treatment that works well for one person may do very little for another. Even when two people share the same diagnosis and similar symptoms, their response to the same medication or diet can be entirely different. This variability is not random. […]
Many people with inflammatory bowel disease (IBD) are told to adjust their fibre intake, but the advice can feel confusing. Some types of fibre seem to help, whilst others trigger symptoms. Resistant starch is often mentioned alongside fibre, yet it behaves quite differently in the gut. Understanding how each one works can help you make […]
If you’ve been managing IBD with a biologic therapy and your doctor or pharmacist mentions switching to a biosimilar, it’s natural to feel uncertain. Understanding what biosimilars are, how they relate to the original biologic, and what the evidence shows can help you feel more confident about the decision. What Are Biologic Medicines? Biologic medicines […]
A new research review has identified adipose tissue and skeletal muscle composition as potential predictors of biologic treatment response in patients with Crohn’s disease. The findings suggest body composition analysis could help clinicians anticipate which patients may experience treatment failure on biologic therapy. Background Context Biologic therapies have transformed management of moderate to severe Crohn’s […]
Authors: Małgorzata Godala, Ewelina Gaszyńska, Łukasz Durko, Ewa Małecka-Wojciesko Journal: Journal of Clinical Medicine Year: 2023 Volume: 12 Article number: 3455 DOI: 10.3390/jcm12103455 Study at a Glance Study type: Prospective questionnaire study Participants: 82 adults with inflammatory bowel disease (IBD) Population studied: 48 people with Crohn’s disease and 34 with ulcerative colitis Intervention or approach […]
Distinguishing between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) can be challenging, especially when symptoms overlap. Both affect the gut and cause abdominal pain, bloating, and bowel habit changes. Yet they differ fundamentally in cause, mechanism, and treatment. One key difference lies in the gut microbiome, the trillions of bacteria and other microorganisms […]
Researchers have identified distinct metabolic signatures in stool samples that may help predict which patients with Crohn’s disease are at higher risk of developing complications. The findings, published in a recent metabolomic profiling study, suggest that non-invasive faecal testing could one day support earlier clinical decision making in inflammatory bowel disease (IBD) management. Background Context […]
When a flare strikes, it can feel like the gut has turned against you. Alongside this, many people with inflammatory bowel disease (IBD) notice changes in their bowel habits and digestive comfort. What is harder to see is the microscopic shift happening simultaneously: changes in the trillions of bacteria that live in the gut. Whether […]
Ready to take control of your gut health?
Join for Free